ImmuCell Corporation (ICCC)
NASDAQ: ICCC
· Real-Time Price · USD
6.26
-0.37 (-5.58%)
At close: Oct 16, 2025, 3:59 PM
6.33
1.12%
After-hours: Oct 16, 2025, 04:10 PM EDT
-5.58% (1D)
| Bid | 5.98 |
| Market Cap | 56.63M |
| Revenue (ttm) | 8.09B |
| Net Income (ttm) | 1.76M |
| EPS (ttm) | 0.21 |
| PE Ratio (ttm) | 29.81 |
| Forward PE | -57.91 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 6.75 |
| Volume | 7,072 |
| Avg. Volume (20D) | 14,379 |
| Open | 6.58 |
| Previous Close | 6.63 |
| Day's Range | 6.25 - 6.64 |
| 52-Week Range | 3.38 - 7.60 |
| Beta | 0.31 |
| Ex-Dividend Date | n/a |
About ICCC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ICCC
Website n/a
2 months ago
-9.23%
ImmuCell shares are trading lower following the re...
Unlock content with
Pro Subscription
3 months ago
-10.76%
ImmuCell shares are trading lower. The company announced it will commence a CEO and president succession plan amid its current CEO's plan to retire in 2026.
